Across TCGA pan-cancer cohorts, MIR8062 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR8062’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR8062 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR8062 is over-expressed in tumor.
KIRC are the cancer types where MIR8062 tumor–normal differential expression is most reproducible.